ADAR1 Capital Management’s Pfizer PFE Stock Holding History

ADAR1 Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-43,000	Closed	-$1.24M	–	281
2023 Q4	$1.24M	Buy	+43,000	New	+$1.3M	0.44%	39

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

ADAR1 Capital Management's PFE Position: Q2 2026 in Review

ADAR1 Capital Management increased its Pfizer (PFE) stake by 226% in Q2 2026, buying an estimated $4.58M and bringing the position to 252,400 shares worth $6.08M. The position accounts for 0.28% of the portfolio, ranked #84.

ADAR1 Capital Management first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

ADAR1 Capital Management held 252,400 shares of Pfizer worth $6.08M as of Q2 2026.
ADAR1 Capital Management bought 175,000 Pfizer shares in Q2 2026, an estimated $4.58M.
Pfizer made up 0.28% of ADAR1 Capital Management's portfolio in Q2 2026, its #84 holding.
ADAR1 Capital Management first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.